NCT06554197 Evaluation of CMV/EBV-CMI in Haploid HSCT
| NCT ID | NCT06554197 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The First Affiliated Hospital of Soochow University |
| Condition | Hematopoietic Stem Cell Transplantation |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-08-13 |
| Primary Completion | 2025-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2024-08-13 with a primary completion date of 2025-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this prospective, open-label, Single Arm, single-center study is to evaluate the cytomegalovirus and Epstein-Barr virus specific immune reestablishment for patients with hemopathy undergoingin prophylaxis for cytomegalovirus in haploid hematopoietic stem cell transplantation(haplo-HSCT) .
Eligibility Criteria
Inclusion Criteria: 1. All patients were diagnosed with hemopathy. 2. All patients should have the indication of Haploidentical hematopoietic stem cell transplant and receive the prophylaxis for cytomegalovirus. 3. All patients should sign an informed consent document indicating that they understand the purpose of and procedures required for the study and be willing to participate in the study. Exclusion Criteria: Patients with any conditions not suitable for the trial (investigators' decision).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06554197 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 60 Years, studying Hematopoietic Stem Cell Transplantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06554197 currently recruiting?
Yes, NCT06554197 is actively recruiting participants. Contact the research team at 13584861215@163.com for enrollment information.
Where is the NCT06554197 trial being conducted?
This trial is being conducted at Suzhou, China.
Who is sponsoring the NCT06554197 clinical trial?
NCT06554197 is sponsored by The First Affiliated Hospital of Soochow University. The trial plans to enroll 60 participants.